A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

Record numbers of people in British Columbia are being vaccinated against COVID-19 and flu, as the province ramps up its ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

The UK Government has recommended offering a COVID-19 booster vaccination in autumn, 2024, to individuals at high risk of ...

Health Canada has approved updated mRNA vaccines targeting the KP.2 COVID-19 subvariant. These vaccines are approved for use ...